Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple ascending oral doses of BI 690517 in healthy Japanese male subjects
jRCT2080224000Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cardiac morbidity comparing BI 690517 with Placebo (2 arms). Primary endpoints: Safety and tolerability of multiple rising doses of BI 690517, Pharmacokinetics of BI 690517 and 1 more. Started Aug 2018; status: completed.
02
Drugs
vicadrostat
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on jRCT2080224000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224000.